Table II.
PEGylation Optimization of BSA Nanoparticles Using Central Composite Design
| Trial | Coded Factors | Experimental Results | ||||
|---|---|---|---|---|---|---|
| X 1 | X 2 | X 3 | X 4 | Molar Ratio of PEGylated Amino Groups per bare BSA Nanoparticles | PEGylation Efficiency (%) | |
| 1 | −1 | −1 | −1 | −1 | 2.77025 | 35 |
| 2 | 1 | −1 | −1 | −1 | 4.2959 | 54 |
| 3 | −1 | 1 | −1 | −1 | 4.62282 | 59 |
| 4 | 1 | 1 | −1 | −1 | 4.96897 | 63 |
| 5 | −1 | −1 | 1 | −1 | 6.469 | 82 |
| 6 | 1 | −1 | 1 | −1 | 7.7767 | 97 |
| 7 | −1 | 1 | 1 | −1 | 5.6292 | 71 |
| 8 | 1 | 1 | 1 | −1 | 7.43605 | 94 |
| 9 | −1 | −1 | −1 | 1 | 2.6741 | 34 |
| 10 | 1 | −1 | −1 | 1 | 5.7254 | 73 |
| 11 | −1 | 1 | −1 | 1 | 5.5587 | 71 |
| 12 | 1 | 1 | −1 | 1 | 7.50743 | 95 |
| 13 | −1 | −1 | 1 | 1 | 3.45615 | 44 |
| 14 | 1 | −1 | 1 | 1 | 7.59077 | 96 |
| 15 | −1 | 1 | 1 | 1 | 6.84077 | 87 |
| 16 | 1 | 1 | 1 | 1 | 7.83436 | 98 |
| 17 | −2 | 0 | 0 | 0 | 3.09718 | 39 |
| 18 | 2 | 0 | 0 | 0 | 7.64846 | 95 |
| 19 | 0 | −2 | 0 | 0 | 4.63564 | 59 |
| 20 | 0 | 2 | 0 | 0 | 7.78308 | 97 |
| 21 | 0 | 0 | −2 | 0 | 5.8664 | 74 |
| 22 | 0 | 0 | 2 | 0 | 7.53948 | 95 |
| 23 | 0 | 0 | 0 | −2 | 5.7446 | 73 |
| 24 | 0 | 0 | 0 | 2 | 6.6613 | 85 |
| 25 | 0 | 0 | 0 | 0 | 7.10359 | 90 |
| 26 | 0 | 0 | 0 | 0 | 7.10361 | 90 |
| 27 | 0 | 0 | 0 | 0 | 7.1036 | 90 |
| 28 | 0 | 0 | 0 | 0 | 7.10359 | 90 |
| 29 | 0 | 0 | 0 | 0 | 7.10358 | 90 |
| 30 | 0 | 0 | 0 | 0 | 7.10362 | 90 |
| 31 | 0 | 0 | 0 | 0 | 7.10359 | 90 |